These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27739482)

  • 1. Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease.
    Kumagai E; Mano Y; Yoshio S; Shoji H; Sugiyama M; Korenaga M; Ishida T; Arai T; Itokawa N; Atsukawa M; Hyogo H; Chayama K; Ohashi T; Ito K; Yoneda M; Kawaguchi T; Torimura T; Nozaki Y; Watanabe S; Mizokami M; Kanto T
    Sci Rep; 2016 Oct; 6():35282. PubMed ID: 27739482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease.
    Huang P; Tu B; Liao HJ; Huang FZ; Li ZZ; Zhu KY; Dai F; Liu HZ; Zhang TY; Sun CZ
    Sci Rep; 2021 Mar; 11(1):5886. PubMed ID: 33723340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease.
    Niu L; Geyer PE; Wewer Albrechtsen NJ; Gluud LL; Santos A; Doll S; Treit PV; Holst JJ; Knop FK; Vilsbøll T; Junker A; Sachs S; Stemmer K; Müller TD; Tschöp MH; Hofmann SM; Mann M
    Mol Syst Biol; 2019 Mar; 15(3):e8793. PubMed ID: 30824564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum chitotriosidase and YKL-40 in acute pancreatitis: Reliability as prognostic marker for disease severity and correlation with inflammatory markers.
    Ünal Çetin E; Kamiş F; Çetin AU; Beyazit Y; Kekilli M
    Turk J Med Sci; 2021 Dec; 51(6):3038-3046. PubMed ID: 34579512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric inpatients.
    Rogalski J; Czarnecka-Chrebelska K; Węglewska K; Płeska K; Gawlik-Kotelnicka O
    Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102366. PubMed ID: 38705235
    [No Abstract]   [Full Text] [Related]  

  • 6. Research advances in serum chitinase-3-like protein 1 in liver fibrosis.
    Hu X; Liu W; Liu J; Wang B; Qin X
    Front Med (Lausanne); 2024; 11():1372434. PubMed ID: 38962736
    [TBL] [Abstract][Full Text] [Related]  

  • 7.  Chemerin, retinol binding protein-4, cytokeratin-18 and transgelin-2 presence in sera of patients with non-alcoholic liver fatty disease.
    Zwolak A; Szuster-Ciesielska A; Daniluk J; Semeniuk J; Kandefer-Szerszen M
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):862-869. PubMed ID: 27740519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study.
    Harrison SA; Ratziu V; Boursier J; Francque S; Bedossa P; Majd Z; Cordonnier G; Sudrik FB; Darteil R; Liebe R; Magnanensi J; Hajji Y; Brozek J; Roudot A; Staels B; Hum DW; Megnien SJ; Hosmane S; Dam N; Chaumat P; Hanf R; Anstee QM; Sanyal AJ
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):970-985. PubMed ID: 32763196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT.
    Yan L; Deng Y; Zhou J; Zhao H; Wang G;
    Infection; 2018 Jun; 46(3):385-393. PubMed ID: 29600444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Serum Biomarkers for Noninvasive Diagnosis and Screening of Nonalcoholic Fatty Liver Disease-Related Hepatic Fibrosis.
    Lin B; Ma Y; Wu S; Liu Y; Liu L; Wu L
    OMICS; 2019 Apr; 23(4):181-189. PubMed ID: 30932742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitinase 3-like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis.
    Higashiyama M; Tomita K; Sugihara N; Nakashima H; Furuhashi H; Nishikawa M; Inaba K; Wada A; Horiuchi K; Hanawa Y; Shibuya N; Kurihara C; Okada Y; Nishii S; Mizoguchi A; Hozumi H; Watanabe C; Komoto S; Yamamoto J; Seki S; Miura S; Hokari R
    Hepatol Res; 2019 Nov; 49(11):1316-1328. PubMed ID: 31250532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of chitinase-3-like protein 1, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 index with shear-wave elastography.
    Mushtaq S; Ghani E; Azam K; Hussain T
    Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):357-362. PubMed ID: 30431458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in serum chitinase 3-like 1 levels correlate with changes in liver fibrosis measured by two established quantitative methods in chronic hepatitis B patients following antiviral therapy.
    Wang L; Liu T; Zhou J; You H; Jia J
    Hepatol Res; 2018 Feb; 48(3):E283-E290. PubMed ID: 28895260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China.
    Jin X; Fu B; Wu ZJ; Zheng XQ; Hu JH; Jin LF; Tang LL
    Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):384-389. PubMed ID: 32540209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of serum chitinase 3-like 1 in hepatitis B-related chronic liver diseases.
    Jiang Z; Wang S; Jin J; Ying S; Chen Z; Zhu D; Xiao B; Hu Y; Qian Y; Cai T; Fu L
    J Clin Lab Anal; 2020 May; 34(5):e23200. PubMed ID: 31916309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases.
    Yeo IJ; Lee CK; Han SB; Yun J; Hong JT
    Pharmacol Ther; 2019 Nov; 203():107394. PubMed ID: 31356910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHI3L1 in the pathophysiology and diagnosis of liver diseases.
    Wang S; Hu M; Qian Y; Jiang Z; Shen L; Fu L; Hu Y
    Biomed Pharmacother; 2020 Nov; 131():110680. PubMed ID: 32861071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitinase-3 like-protein-1 function and its role in diseases.
    Zhao T; Su Z; Li Y; Zhang X; You Q
    Signal Transduct Target Ther; 2020 Sep; 5(1):201. PubMed ID: 32929074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Chitinase 3-like 1 (CHI3L1) as a noninvasive biomarker of hepatic fibrosis in patients with Hepatitis B virus-related compensated chronic liver disease.
    Das A; Kamrul-Hasan A; Kabir MR; Das S; Zaki K; Al Mahtab M
    J Family Med Prim Care; 2021 Apr; 10(4):1694-1698. PubMed ID: 34123914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in Chitinase 3-Like Protein 1 Levels Reflects Improvement in Liver Fibrosis after HCV Eradication.
    Kang Q; Chen J; Luo H; Tan N; Gao H; Zhang X; Yu M; Liu D; Xi H; An Y; Han Y; Cheng R; Xu X
    Dis Markers; 2020; 2020():8539804. PubMed ID: 33082884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.